<DOC>
	<DOCNO>NCT01229267</DOCNO>
	<brief_summary>This study determine whether investigational V212 reduces incidence herpes zoster ( HZ ) compare placebo administer recipient autologous hematopoietic cell transplant ( HCT ) .</brief_summary>
	<brief_title>A Study Evaluate Safety Efficacy Inactivated Varicella-zoster Vaccine ( VZV ) Preventative Treatment Herpes Zoster ( HZ ) HZ-related Complications Participants Undergoing Hematopoietic Cell Transplants ( HCTs ) ( Study No . V212-001 AM4 )</brief_title>
	<detailed_description />
	<mesh_term>Herpes Zoster</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Men woman least 18 year age Has prior history varicella , antibody VZV ( document prior receipt blood product ) , residence country endemic VZV infection â‰¥30 year participant &lt; 30 year old , attend primary secondary school country endemic VZV infection . Scheduled undergo autologous hematopoietic cell transplant within 60 day enrollment Is highly unlikely conceive time period start 2 week prior enrollment 6 month last vaccination dose Female participant childbearing potential must negative serum urine pregnancy test . History hypersensitivity reaction vaccine component Prior history herpes zoster within 1 year enrollment Prior receipt varicella zoster vaccine More 2 relapse underlie cancer ( participant Hodgkin 's lymphoma may 2 relapse ) Expectation tandem transplant procedure Is expect receive &gt; 6 month ( &gt; 180 day ) prophylactic antiviral therapy postHCT . Is pregnant breastfeed expect conceive within period 2 week prior enrollment 6 month last vaccination dose . Has receive live virus vaccine schedule receive live virus vaccine period 4 week prior Dose 1 28 day Postdose 4 . Has receive inactivate vaccine schedule receive inactivated vaccine period 7 day prior 28 day follow Doses 1 4 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Herpes zoster</keyword>
	<keyword>vaccine</keyword>
	<keyword>herpes zoster-related complication</keyword>
	<keyword>immunocompromised</keyword>
	<keyword>autologous hematopoietic cell transplant</keyword>
</DOC>